A novel role of renin inhibitor in the complement cascade.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30243307.
- Also identified by DOI 10.1016/j.kint.2018.05.025.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Aberrant regulation of an alternative pathway of the complement system could be a therapeutic target of C3 glomerulopathy, including dense deposit disease. In the current issue, Békássy and colleagues provide data on enzymatic conversion of C3 by renin in vitro and on the efficacy of a direct renin inhibitor, aliskiren, on systemic and renal complement activation in patients with dense deposit disease.
Medical subject headings
- Glomerulonephritis, Membranoproliferative
- Renin